| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
64,998 |
59,322 |
$16.60M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
88,223 |
81,943 |
$11.90M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
38,800 |
35,642 |
$8.75M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
23,205 |
20,556 |
$1.29M |
| 71045 |
Radiologic examination, chest; single view |
34,441 |
31,295 |
$1.12M |
| 41899 |
Unlisted procedure, dentoalveolar structures |
953 |
867 |
$1.02M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
26,208 |
23,864 |
$743K |
| 80053 |
Comprehensive metabolic panel |
73,427 |
65,900 |
$711K |
| 87400 |
|
46,796 |
21,602 |
$656K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
81,201 |
72,912 |
$605K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
25,443 |
22,612 |
$585K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
20,125 |
12,153 |
$426K |
| 59025 |
Fetal non-stress test |
7,186 |
6,192 |
$382K |
| J3490 |
Unclassified drugs |
59,418 |
34,818 |
$363K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
14,299 |
8,486 |
$360K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,066 |
3,576 |
$285K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
367 |
324 |
$254K |
| 87430 |
|
15,055 |
14,084 |
$240K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
3,252 |
2,382 |
$220K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,997 |
8,662 |
$211K |
| 84703 |
|
16,735 |
14,958 |
$199K |
| 81001 |
|
55,022 |
50,226 |
$185K |
| 87070 |
|
13,295 |
12,508 |
$160K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,247 |
664 |
$126K |
| 84484 |
|
14,804 |
8,789 |
$118K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
7,792 |
6,852 |
$116K |
| 70450 |
Computed tomography, head or brain; without contrast material |
614 |
534 |
$115K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,496 |
2,359 |
$112K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
259 |
257 |
$92K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
5,400 |
4,785 |
$87K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
2,566 |
2,484 |
$85K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,385 |
3,282 |
$81K |
| 83690 |
|
10,768 |
9,887 |
$80K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
7,646 |
6,977 |
$72K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
2,606 |
2,224 |
$68K |
| 71046 |
Radiologic examination, chest; 2 views |
2,025 |
1,982 |
$65K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
7,568 |
6,870 |
$64K |
| J7050 |
Infusion, normal saline solution, 250 cc |
4,465 |
1,203 |
$55K |
| 95811 |
|
115 |
115 |
$48K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
655 |
498 |
$39K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,585 |
4,983 |
$36K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,373 |
2,177 |
$36K |
| 83605 |
|
3,248 |
2,611 |
$35K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
926 |
865 |
$31K |
| 81025 |
|
3,042 |
2,848 |
$29K |
| 87420 |
|
1,504 |
1,380 |
$28K |
| 87536 |
|
467 |
448 |
$27K |
| A9270 |
Non-covered item or service |
65,384 |
34,003 |
$26K |
| 87077 |
|
2,497 |
2,052 |
$25K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,264 |
1,243 |
$23K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
295 |
267 |
$18K |
| 0002A |
|
336 |
331 |
$15K |
| J2704 |
Injection, propofol, 10 mg |
1,602 |
1,192 |
$15K |
| 96367 |
|
175 |
103 |
$15K |
| 0001A |
|
373 |
369 |
$14K |
| 36415 |
Collection of venous blood by venipuncture |
5,725 |
5,268 |
$14K |
| G0378 |
Hospital observation service, per hour |
67 |
61 |
$13K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
439 |
402 |
$12K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
439 |
402 |
$12K |
| 11045 |
|
30 |
24 |
$11K |
| 86361 |
|
316 |
304 |
$11K |
| 83735 |
|
1,576 |
1,311 |
$10K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
14 |
13 |
$9K |
| 80061 |
Lipid panel |
625 |
617 |
$9K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,081 |
971 |
$9K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
984 |
853 |
$8K |
| 72114 |
|
161 |
153 |
$8K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
701 |
696 |
$8K |
| 77336 |
|
65 |
25 |
$6K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
80 |
64 |
$6K |
| 85027 |
|
747 |
678 |
$5K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
25 |
25 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
163 |
146 |
$4K |
| 72052 |
|
38 |
38 |
$3K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
169 |
48 |
$3K |
| 72110 |
|
114 |
113 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
199 |
196 |
$3K |
| 74018 |
|
89 |
88 |
$3K |
| 83880 |
|
97 |
92 |
$3K |
| 85730 |
|
573 |
522 |
$3K |
| 80076 |
|
335 |
322 |
$3K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
49 |
39 |
$2K |
| 85610 |
|
643 |
589 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
73 |
71 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
207 |
190 |
$2K |
| 86780 |
|
108 |
104 |
$2K |
| 94726 |
|
15 |
13 |
$2K |
| 76001 |
|
13 |
13 |
$1K |
| 87631 |
|
15 |
12 |
$1K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
764 |
342 |
$1K |
| 87641 |
|
77 |
75 |
$1K |
| 86850 |
|
117 |
114 |
$1K |
| 82565 |
|
209 |
209 |
$1K |
| 94729 |
|
13 |
12 |
$756.21 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
94 |
82 |
$580.69 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
56 |
50 |
$467.68 |
| 87486 |
|
15 |
12 |
$448.23 |
| 87581 |
|
15 |
12 |
$448.23 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
52 |
51 |
$400.41 |
| 72020 |
|
13 |
13 |
$400.30 |
| 84439 |
|
52 |
49 |
$396.07 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
92 |
87 |
$324.80 |
| 82805 |
|
14 |
13 |
$318.24 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
14 |
14 |
$290.48 |
| 84702 |
|
25 |
24 |
$289.44 |
| 82533 |
|
13 |
13 |
$243.84 |
| 87040 |
|
84 |
41 |
$239.16 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
28 |
28 |
$237.91 |
| 86901 |
|
100 |
98 |
$231.22 |
| 86900 |
|
100 |
98 |
$230.02 |
| 86762 |
|
13 |
12 |
$209.76 |
| 86787 |
|
13 |
12 |
$188.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
44 |
24 |
$187.19 |
| 87210 |
|
47 |
39 |
$186.05 |
| 86200 |
|
13 |
13 |
$177.43 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
13 |
13 |
$174.22 |
| 87340 |
|
13 |
12 |
$135.79 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
34 |
24 |
$134.77 |
| 82800 |
|
15 |
13 |
$83.24 |
| 86592 |
|
14 |
13 |
$58.41 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
15 |
12 |
$27.84 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
17 |
12 |
$18.74 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
110 |
107 |
$3.32 |
| J7999 |
Compounded drug, not otherwise classified |
13 |
13 |
$0.00 |